LAWSON BYRON (SVP/Chief Commercial Officer) reported 1 transaction at HTG MOLECULAR DIAGNOSTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 4/4/2022ACC: 0001209191-22-022392
Officer· SVP/Chief Commercial Officer
Since Jan 2020
-23.00
Net shares
Net seller
$31.97
Total sold
0
Open market trades
0B · 0S
1
Total transactions
23.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−23.00
Price / share
$1.39
Trade value
$31.97
% of position
0.6%
3/31/2022
4.08K→4.06K
Total
Net shares
−23.00
Net value
-$31.97
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2022 | F · Tax Withholding | −23.00 | $1.39 | $31.97 | 0.6% | 4.08K | 4.06K |
| Total | −23.00 | -$31.97 | ||||||
Derivative Transactions0
No derivative transactions reported